InsiderTrades

Form 4 for SRPT Sarepta Therapeutics, Inc.

Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-04 · accession 0001209191-22-017347 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-08 2022-03-07 SRPT Estepan Ian Michael CFO A - Grant $0.00 +8,000 32.7K +32% $0
DM 2022-03-08 2022-03-04+ SRPT Estepan Ian Michael CFO F - Tax $79.24 -1,706 25.1K -6% -$135.2K
D 2022-03-08 2022-03-07 SRPT Estepan Ian Michael CFO A - Grant $0.00 +48.0K 48.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-07 A A 8,000 $0.00 32,671 D — — (F3) The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
2 Common Common Stock 2022-03-07 F D 398 $79.36 24,671 D — — (F2) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 5, 2018.
3 Common Common Stock 2022-03-04 F D 1,308 $79.20 25,069 D — — (F1) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021.
4 Derivative Stock Option (right to sell) 2022-03-07 A A 48,000 $0.00 48,000 D $80.42 · 2023-03-07 to 2032-03-07 48,000 Common Stock (F4) Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.